Post-earnings recap
Reported
Mon, Aug 11, 2025
EPS actual
$-0.33
EPS est.
$-0.29
EPS surprise
-11.86%
1-day move
-2.79%
Roivant Sciences reported a loss of $0.33 per share, which was worse than expected. The stock fell by 2.79% in response to these results. Without revenue figures or additional guidance, investors may be cautious about the company's near-term outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.33 | N/A | -11.86% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—